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The addition of carbohydrate (CHO) in the form of simple sugars to creatine (Cr) supplements is central. The study aimed to
determine whether ingestion of glucose (Glu) simultaneously with Cr and glycerol (Cr/Gly) supplement is detrimental to plasma
lipids of endurance-trained individuals and find outwhethermodification arising can be attenuated by replacing part of theGluwith
alpha lipoic acid (Ala). Twenty-two endurance-trained cyclists were randomized to receive Cr/Gly/Glu (11.4 g Cr-H
2
O, 1 g Gly/kg
BM, and 150 g Glu) or Cr/Gly/Glu/Ala (11.4 g Cr-H
2
O, 1 g Gly/kg BM, 100 g Glu, and 1 g Ala) for 7 days. Fasting concentration of
TAG increased significantly (P < 0.01) after supplementation with Cr/Gly/Glu (before: 0.9 ± 0.2mmol/L; after: 1.3 ± 0.4mmol/L)
and Cr/Gly/Glu/Ala (before: 0.8 ± 0.2mmol/L; after: 1.2 ± 0.5mmol/L) but changes were not different between the groups.
Supplementation significantly (P < 0.05) increased the TAG to HDL-cholesterol ratio but had no effect on fasting concentration
of total, HDL-, and LDL-cholesterol and insulin resistance. Thus, addition of Glu to Cr containing supplements enhances plasma
TAG concentration and the TAG to HDL-cholesterol ratio and this enhancement cannot be attenuated by partial replacement of
Glu with Ala.
1. Introduction
Creatine (Cr) is a guanidine compound which is naturally
synthesised in the liver, kidney, and pancreas from amino
acids arginine, glycine, and methionine [1]. Cr can also be
obtained through diet, especially from meat and fish [2].
DietaryCr is taken up to tissues, including skeletalmuscle [3].
Enhancement in muscle Cr content facilitates growth in lean
bodymass, strength, and high intensity exercise performance
[4]. It also enhances fluid retention and provides the improve-
ment in thermoregulation during exercise in the heat [5, 6].
As a consequence of these findings, Cr supplementation
has become popular amongst recreational and professional
athletes.
In vitro [7] and in vivo [8] studies demonstrated that Cr
uptake by rat skeletal muscle is increased by the presence of
insulin. In humans, carbohydrate (CHO) ingestion, aimed at
rising plasma insulin concentration, has been demonstrated
to enhance both whole body Cr retention [9] and skeletal
muscle Cr accumulation [10]. It has been suggested that
muscle Cr accumulation is maximised when ∼100 g of simple
sugars is ingested with a typical 5 g dose of Cr supplement
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[11]. The amount of Glu required can be expected to increase
available CHO intake above the habitually consumed level.
Safety of such a high CHO intake while applying Cr supple-
mentation protocols has not been investigated yet.
Some studies have demonstrated that increase in CHO
intake may have detrimental impact on concentration of
plasma lipids not only in sedentary [12–15] but also in
well-trained individuals [16–18]. For example, in distance
runners consumption of a high CHO diet for two weeks
increased concentration of plasma triglycerides (TAG) and
total and LDL-cholesterol and reduced concentration of
HDL-cholesterol [16]. These results were supported by
another study which examined the effects of 12-week high
CHO diet on plasma lipids in 32 endurance-trained cyclists
and found a significant increase in plasma concentration of
total cholesterol and TAG [17]. A recent study also showed
that in 9 trained males after 5 days on diet providing 70%
of energy from CHO, plasma concentration of TAG was
increased and concentration of HDL-cholesterol decreased
[18]. Based on population studies, these changes would be
expected to increase the risk of coronary heart disease
[19].
Due to these possible detrimental changes in plasma
lipids induced by high glucose (Glu) intake consumed with
Cr containing supplements, there has been a search for
alternative agents that stimulate insulin secretion and thus
may be expected to enhance skeletal muscle Cr uptake. We
previously demonstrated that the same increase in total body
water and improvement in thermoregulatory and cardiovas-
cular responses during exercise in the heat can be achieved
when part of the Glu in the Cr/glycerol (Gly) hyperhydrating
supplement is replaced with alpha lipoic acid (Ala) [20],
a compound that has insulin-potentiating activity [21]. It
remains unclear whether expected changes in plasma lipids
can be attenuated by partial replacement of Glu with Ala.
This study aimed to determine whether ingestion of Glu
simultaneously with Cr/Gly supplement is detrimental to
the fasting concentration of plasma TAG and the TAG to
HDL-cholesterol ratio, an independent risk factor of car-
diometabolic risk [19, 22] of endurance-trained individuals,
and find out whether modifications arising from Cr/Gly/Glu
supplementation can be attenuated by replacing part of the
Glu with Ala (Ala).
2. Methods
2.1. Participants. Twenty-two healthy endurance-trained
males took part in the study. Physical characteristics of the
participants are presented in Table 1. Eligibility was assessed
via an interview and a medical questionnaire. During the
interview, the investigator confirmed that participants had
not been supplemented with Cr 6–8 weeks preceding the
study, as this was an exclusion criterion. Nevertheless,
the fact that previous Cr supplementation would act as
an exclusion criterion was withheld from the partici-
pants. Upon recruitment, two participants were excluded
from the Cr/Gly/Glu group as fasting plasma triglyceride
concentration exceeded recommended healthy concentra-
tion of <1.7mmol/L [23].
Table 1: Physical characteristics of participants in Cr/Gly/Glu (𝑛 =
11) and Cr/Gly/Glu/Ala (𝑛 = 11) groups. Data presented as mean ±
SD.
Cr/Gly/Glu Cr/Gly/Glu/Ala
Age (y) 31 ± 10.5 32 ± 8.7
Height (cm) 177 ± 7.5 181 ± 5.4
Weight (kg) 71 ± 6.3 78 ± 8.4∗
BMI (kg/m2) 23 ± 1.8 24 ± 2.1
VO2 max (mL/kg/min) 61 ± 3.9 59 ± 4.5
∗Significantly different (𝑃 < 0.05) from Cr/Gly/Glu group.
2.2. Study Design. Study participants were randomly as-
signed to receive Cr/Gly/Glu or Cr/Gly/Glu/Ala supplements
for 7 days. Fasting blood samples were obtained and body
weight was measured before and after 7 days of the supple-
mentation. On the days of the blood sampling participants
were also asked to provide a baseline urine sample and
after this orally ingest a dose of deuterium oxide (D
2
O)
(Ontario Hydro, Canada). Six hours after the D
2
O ingestion
participants were asked to provide another urinary sample.
During the 7 days preceding the supplementation and the 7
days of supplementation participants were asked to record all
food and drink consumed.
2.3. Experimental Procedures
2.3.1. Anthropometry and Body Composition. Measurements
of bodymass were taken using bioelectrical impedance scales
(TBF-300, TANITA, Cranlea, UK). Height was determined
using standard protocols [24].
2.3.2. Supplementation. Subjectswerematched for bodymass
and randomized in a double-blind fashion to receive Cr, Gly,
and Glu or Cr, Gly, Glu, and Ala. Subjects were separated into
two groups because of the long washout period associated
with Cr [25].The Cr/Gly/Glu group were instructed to ingest
20 g/day (4×5 g/day) of Crmonohydrate (CreapureCrMono-
hydrate, Reflex Nutrition Ltd., UK), 2 g/kg of body mass per
day (4×0.5 g/kg of bodymass per day) of Gly (Glycerin, Care
Plus, Huddersfield, UK), and 150 g/day (4×37.5 g/day) of Glu
(SISGO Electrolyte Drink Powder, Ashwood Laboratories,
Lancashire, England) and the Cr/Gly/Glu/Ala group were
instructed to ingest 20 g/day (4 × 5 g/day) of Cr monohydrate
(Creapure Cr Monohydrate, Reflex Nutrition Ltd., UK),
2 g/kg of body mass per day (4 × 0.5 g/kg of body mass
per day) of Gly (Glycerin, Care Plus, Huddersfield, UK),
100 g/day (4 × 25 g/day) of Glu (SISGO Electrolyte Drink
Powder, Ashwood Laboratories, Lancashire, England), and
1 g/d (4 × 250mg/day) of Ala (Racemic mixture [R and S]
Pure Bulk, USA). Daily intake of Cr, Gly, and Glu and Ala
in Cr/Gly/Glu and Cr/Gly/Glu/Ala groups is presented in
Table 2. Subjects were asked to avoid caffeine and alcohol
intake for the full length of their participation in the study.
2.3.3. Dietary Intake. For dietary intake records the partici-
pants were provided with food diaries and electronic scales
(Salter Housewares, Kent, UK). Instructions of how to use
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Table 2: Daily intake of creatine (Cr), glycerol (Gly), and glucose
(Glu) and alpha lipoic acid (Ala) in Cr/Gly/Glu and Cr/Gly/Glu/Ala
groups.
CR Gly Glu Ala
Cr/Gly/Glu 20 (g) 1 g/kg/BM 150 (g) —
Cr/Gly/Glu/Ala 20 (g) 1 g/kg/BM 100 (g) 1000 (mg)
the scales and how to complete properly the diaries were
given to each participant individually. Participantswere asked
to record the amount of all the food and drinks consumed
and report the time of consumption. They were also asked to
record the amount of all food and drink which was left after
eating. The dietary records were analysed for macronutrient
and energy intake using dietary analysis software Windiets
2005 (The Robert Gordon University, Aberdeen, Scotland,
UK). Amount of CHO provided by the supplements was
added to amount of CHO provided by the diet. Since Gly
is defined by the US Food and Drug Administration (FDA)
as a CHO providing 4.32 kcal per gram, this was taken
into consideration when calculating the amount of CHO
consumed in the supplementation study.
2.3.4. Blood Collection, Plasma Preparation, and Analysis.
Subjects reported to the laboratory after an overnight 8-
hour fast. On arrival to the laboratory subjects were asked
to lay comfortably in a supine position for the duration of
10 minutes and then venous blood sample was collected
in K
3
EDTA tube (BD, Vacutainer System, Franklin Lakes,
NJ, USA). Tubes containing blood sample were immediately
placed on ice and then centrifuged for 15minutes at 3000 rpm
(Hettich D-78532 Universal 320 R Centrifuge, Tuttlingen,
Germany). Plasma was dispensed in 0.5mL aliquots into
labeled sterilised microcentrifuge cap tubes (red microcen-
trifuge tubes with cap, FR74073, Fischer Scientific, UK) and
kept at −80∘C until analyses.
Plasma concentration of TAG and total and HDL-
cholesterol was analyzed by enzymatic colorimetric meth-
ods using commercially available kits (Roche Diagnostics
GmbH, Mannheim, Germany). Plasma concentration of
LDL-cholesterol was calculated using the Friedewald equa-
tion [26]. Glu was assayed using the hexokinase method,
utilising a Roche kit (Roche Diagnostics GmbH, Mannheim,
Germany). Glu, TAG, and total and HDL-cholesterol assays
were performed on a Cobas Mira Plus (ABX Diagnostics,
France). All samples for each participant were analysed in
duplicate. The accuracy and precision of the assays was
monitored using quality control sera (Roche Diagnostics
GmbH, Mannheim, Germany; Randox Laboratories Ltd.,
Co., Antrim, Ireland; Kamiya Biomedical, Seattle, USA).
The coefficients of variation were <3.1% for all calorimetric
assays.
Plasma concentration of insulin was measured using an
enzyme-linked immunoassay (ELISA) procedure based on a
“sandwich” technique with the use of a commercially avail-
able ELISA kit following manufacturer instruction (Insulin
ELISA kit 10-1113-01, Mercodia AB, Sylveniusgatan 8A, SE-
754 50, Uppsala, Sweden). All samples for each participant
were analysed in duplicate.The accuracy and precision of the
assays was monitored using quality control sera (Diagnostic
System Labs, TX, USA, and Linco Research Inc., St. Louis,
MO, USA). Coefficients of variation were <4.0%. Fasting
insulin and Glu were used for the assessment of insulin
resistance by Homeostasis Model Assessment of Insulin
Resistance (HOMAIR). For the insulin assay the coefficient
of variation was <4.0%.
2.3.5. Total Body Water (TBW) Determination. On arrival
to the laboratory, participants provided a baseline urine
sample and were then asked to orally ingest 0.5 g⋅kg−1 BM
of D
2
O (Ontario Hydro, Canada). To evaluate the volume
of isotopic distribution in body water, urine sample was
collected again after 6 h. Both urine samples were collected
in a dry plastic container. For purposes of analysis, the
investigator transferred 2mL from all urine samples from
the dry plastic containers to glass vessels and stored them
in −20∘C. Urine samples were then analyzed by an isoprime
isotope ratiomass spectrometer (Elementar Ltd.,Manchester,
UK), coupled to a Eurovector gas chromatograph (GC)
fitted with an HT300A autosampler, as described elsewhere
[27].
2.3.6. Statistical Analysis. Data were assessed for normality of
distribution using Anderson-Darling test. Statistical analysis
was carried out using the 2-way ANOVA (i.e., before versus
after supplementation for each treatment). Independent sam-
ple 𝑡-tests were used to examine whether changes induced
in plasma lipids, Glu, and insulin resistance were different
between the two treatments. Data was described as mean ±
SD. All statistical analysis was carried out using SPSS for
Windows version 17.0. Statistical significance was set at 𝑃 ≤
0.05.
2.3.7. Ethical Considerations. All participants gave their
informed consent and the study was approved by the Ethics
Committee for Nonclinical Research Involving Human Sub-
jects, University of Glasgow, and was performed according
to the code of ethics of the World Medical Association
(Declaration of Helsinki).
3. Results
Data on nutrient and energy intake during the 7 days
preceding supplementation and the 7 days of supplemen-
tation are presented in Table 3. During the week preced-
ing supplementation, there were no significant differences
between Cr/Gly/Glu and Cr/Gly/Glu/Ala groups in energy
and macronutrient intake. Being on both supplementation
regimes significantly increased intake of available CHO (𝑃 <
0.001) and the percentage of energy provided by CHO (𝑃 <
0.001) while significantly reducing intake of fat (𝑃 < 0.01)
and the percentage of energy obtained from fat (𝑃 < 0.01).
During supplementation week, intake of starch (𝑃 < 0.01)
was significantly lower whereas intake of sugars (𝑃 < 0.01)
was significantly higher than that during the days of the
habitual intake in both groups. Averaged daily energy intake,
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Table 3: Averaged daily energy, carbohydrate (CHO), fat, and
protein intake in Cr/Gly/Glu and Cr/Gly/Glu/Ala groups before
(habitual diet) and during 7 days of supplementation. Values are
mean ± SD.
Cr/Gly/Glu Cr/Gly/Glu/Ala
Before During Before During
Available CHO (g) 470 ± 115 613 ± 61∗ 376 ± 88 514 ± 50∗
Sugar (g) 161 ± 52 389 ± 36∗ 128 ± 43 325 ± 21∗
NMES (g) 86 ± 14 58 ± 15a 69 ± 39 35 ± 13a
Starch (g) 226 ± 67 178 ± 44a 248 ± 172 158 ± 30a
Fibre (g) 22 ± 8 17 ± 7 19 ± 4 16 ± 6
Fat (g) 104 ± 38 69 ± 11a 101 ± 28 83 ± 27a
Protein (g) 86 ± 16 101 ± 15 114 ± 29 112 ± 31
Available CHO
(g/kg/BM) 7 ± 2 9 ± 2
∗ 5 ± 1 7 ± 1∗
Energy (MJ/day) 10 ± 2 14 ± 1∗ 11 ± 1 14 ± 2∗
From CHO (%) 53 ± 4 68 ± 2∗ 50 ± 10 60 ± 5∗
From fat (%) 37 ± 6 19 ± 2a 35 ± 7 24 ± 9a
From protein (%) 14 ± 3 20 ± 8 12 ± 2a 18 ± 4
Note: NMES: non-milk extrinsic sugars. ∗Significantly (𝑃 < 0.01) higher
than before; asignificantly (𝑃 < 0.01) lower than before.
calculated by adding amount of Glu and Gly provided by
supplements, was significantly (𝑃 < 0.01) higher during
supplementation than during the presupplementation week
but supplementation had no effect on body mass in the
Cr/Gly/Gly (before: 70.0 ± 5.8 kg; after: 71.2 ± 5.3 kg, 𝑃 >
0.05) and the Cr/Gly/Glu/Ala (before: 78.0 ± 8.5 kg; after:
79.2±8.4 kg, 𝑃 > 0.05) groups. On the other hand both types
of supplementation induced significant (𝑃 < 0.05) increase
in TBW (Cr/Gly/Gly: 1.7 ± 1.1 L; Cr/Gly/Glu/Ala: 1.2 ± 0.5 L,
𝑃 < 0.05) and the increase in TBW tended (𝑟 = 0.40,
𝑃 = 0.06) to correlate with the changes in body mass.
Fasting concentration of plasma lipids is presented in
Figure 1. The concentration of TAG and total, LDL-, and
HDL-cholesterol measured before supplementation was not
significantly different between groups. Fasting concentration
of plasma TAG increased significantly (𝑃 < 0.01) after sup-
plementation with Cr/Gly/Glu (before: 0.90 ± 0.19mmol/L;
after: 1.30 ± 0.44mmol/L, 𝑃 < 0.01) and Cr/Gly/Glu/Ala
(before: 0.77 ± 0.25mmol/L; after: 1.2 ± 0.54mmol/L, 𝑃 <
0.01). The TAG to HDL-cholesterol ratio increased signifi-
cantly following supplementation with Cr/Gly/Glu (before:
0.5 ± 0.07; after: 0.8 ± 0.19; 𝑃 = 0.01) and Cr/Gly/Glu/Ala
(before: 0.5 ± 0.1; after: 0.8 ± 0.2; 𝑃 = 0.002). The
increase in plasma TAG concentration and in the TAG to
HDL-cholesterol ratio was not significantly different between
groups. Supplementation had no effect on fasting concentra-
tion of total, HDL-, and LDL-cholesterol.
Before supplementation, the concentration of fasting Glu
and insulin and insulin resistance evaluated from HOMAIR
were not significantly different between Cr/Gly/Glu and
Cr/Gly/Glu/Ala groups. None of the supplements had impact
on plasma Glu or insulin concentrations and HOMAIR
(Table 4).
Table 4: Plasma concentration of fasting glucose and insulin, and
homeostasis model assessment of insulin resistance (HOMAIR) pre-
ceding supplementation (Pre) and after 7 days of supplementation
(Post). Values are means ± SD.
Cr/Gly/Glu Ala /Cr/Gly/Glu
Pre Post Pre Post
Glucose (mmol/L) 4.8 ± 0.4 4.9 ± 0.2 4.9 ± 0.5 4.9 ± 0.4
Insulin (𝜇lU/mL) 2.8 ± 0.4 2.9 ± 0.6 2.6 ± 0.6 2.8 ± 0.6
HOMAIR 0.6 ± 0.1 0.6 ± 0.1 0.6 ± 0.2 0.6 ± 0.2
4. Discussion
This study found that 7-day supplementation of endurance-
trained individuals with hyperhydrating Cr/Gly supplement
containing either 150 or 100 g of Glu significantly increased
daily intake of available CHO and induced increase in
fasting concentration of plasma TAG and the TAG to
HDL-cholesterol ratio, an independent risk factor of car-
diometabolic risk [19, 22]. We also found that these changes
cannot be attenuated by replacing 50 g of Glu with Ala,
another insulinotropic compound, required to promote Cr
uptake by the skeletal muscle. We note that in endurance-
trained athletes modified TAG concentrations remained
below the unhealthy range [23] and suggest that increased
intake of CHOduringCr supplementation does not represent
a deleterious effect on cardiometabolic risk. However, in less
trained individuals or habitual gym users often Cr loading
when combined with Glu or other forms of simple sugars can
be expected to increase plasma TAG concentration and the
TAG to HDL-cholesterol ratio to higher levels. The latter is
solely an extrapolation from our findings and may be worth
investigating through future studies.
Our finding is that seven-day consumption of Cr based
supplements containing Glu increased concentration not
only in sedentary [28–31] but also in endurance-trained
athletes. Plasma concentration of TAG is in consistency
with the previous evidence showing that, in trained indi-
viduals, short-term enhanced CHO intake leads to signif-
icant increase in fasting plasma TAG concentrations [16–
18]. The TAG to HDL-cholesterol ratio, an independent
risk factor of cardiometabolic risk [22], has also increased
significantly following supplementationwith Cr/Gly/Glu and
with Cr/Gly/Glu/Ala. Thus, our findings contribute to the
notion that, regardless of endurance training being associated
with efficient metabolism of plasma TAG and prolonged
survival of HDL lipoproteins [32], endurance athletes cannot
withstand the impact of acutely enhanced CHO intake.Thus,
modification of macronutrient composition of the diet due to
increased CHO intake enhances plasma TAG.
Previous studies show that Ala, a naturally existing
compound that acts as a coenzyme for pyruvate dehydroge-
nase and 𝛼-ketoglutarate dehydrogenase, plays a key role in
bridging glycolysis and the citric acid cycle and regulates Glu
and lipid metabolism and has insulin-potentiating activity
[21]. Thus, this study also aimed to find out whether changes
of plasma lipids induced by Cr supplementation protocols,
considering CHO addition, can be prevented or at least
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Figure 1: Fasting concentrations of plasma lipids at baseline (Pre) are represented with white bars and after 7 days of supplementation (Post)
represented with black filled bars ∗Significantly different (𝑃 < 0.05) from presupplementation in corresponding group. Values are presented
as means ± SD.
attenuated when 50 grams of Glu is replaced with Ala. We
found that the extent of increase in plasma concentration
of TAG was not significantly different between the group
consuming 150 and the group consuming 100 g Glu plus
Ala. This is not surprising since increase in CHO intake
was significant and associated with reduction in fat intake in
both groups. Thus, in both groups, diets consumed during
the seven days of the supplementation period were high
CHO/low fat diets and differ significantly from habitual
diets. Our data suggest that diminishing daily Glu intake
by 50 g and replacing that amount of Glu with Ala cannot
prevent increase in plasma concentration of TAG induced by
incorporation of Glu.
Prior supplementation plasma concentration of TAG was
low and within a range of 0.9–1.2 and 0.4–1.2mmol/L in the
Cr/Gly/Glu and Cr/Gly/Glu/Ala groups, respectively, which
is in agreement with other studies investigating lipid profiles
of trained individuals [33]. After 7 days of consumption of
both supplements, plasma TAG concentration was still below
1.5mmol/L, a concentration which is known to have a detri-
mental impact on distribution of LDL subtractions, leading
to the increase in proportion of LDL
3
particles [34], the most
atherogenic lipoprotein particles. In addition, regardless of
other studies reporting that, in athletic individuals, increase
in plasma TAG leads to a synergistic decrease in HDL-
cholesterol [16–18] the present study found that, after 7 days
of enhanced CHO intake, plasma concentration of HDL-
cholesterol was not diminished. Thus, endurance-trained
individuals with baseline concentration of plasma TAG being
within healthy range [23] should be safe to enhance intake of
simple sugars required for promotion of muscle Cr uptake. In
addition, since TAG-raising effect of high CHO is transient
and disappears with time [35], it could be suggested that
short-term high intake of CHO should not be of any concern
for healthy and well-trained individuals. This, however, may
not be the case for less trained individuals such as habitual
gym users who often combine Cr loading with enhanced
intake of simple sugars and for sedentary overweight individ-
uals in whom higher-CHO diets, particularly those enriched
in refined CHO, create a metabolic state that promotes
development of atherosclerosis [29, 36].
From the athletes’ point of view increase in plasma TAG
concentration found after both types of supplementationmay
be considered as beneficial rather than detrimental change.
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Indeed, the increase in plasma TAG concentration may be
expected to increase VLDL-derived fatty acid availability and
rates of fat oxidation during exercise and thus have a potential
to slow the rate of glycogen utilization and delay the onset
of fatigue during sport competition and training [31]. This
hypothesis requires evaluation since in sedentary individuals
short-term adaptation to a high CHO diet induces metabolic
alterations suggestive of repartitioning fatty acids away from
oxidation toward esterification in both liver and muscle
[31]. In addition, increase in plasma TAG concentration
and the TAG to HDL-cholesterol ratio due to Cr/Gly/Glu
and Cr/Gly/Ala supplementation can be outweighed by the
enhancement in muscle glycogen accumulation [37] and
expansion of water compartments within the human body
and thus attenuation in the rise in heart rate and reduction
in thermal and cardiovascular strain during exercise in the
heat without negatively impacting exercise economy [5].
Based on the data obtained from dietary records, we
found that during the days of supplementation energy intake
was higher than habitual energy intake. Thus, it could be
argued that supplementation induced increase in plasma
TAG concentration was a consequence not only of enhanced
CHO intake but also of change in energy balance. How-
ever, both interventions had no significant impact on body
mass, which implies that energy intake, during interventions,
was not different from habitual energy intake. This implies
that food intake recording might have been more accurate
during supplementation days. Indeed, during interventions
participants were contacted by the researchers daily as a
means of enhancing compliance to interventions and also
to remind participants to record food and drink intake.
It is also important to note that only long-term energy
imbalance leading to weight gain was found to be associated
with an increase in plasma TAG concentrations [38], while
acute dietary energy surplus (∼3MJ) had no effect on basal
VLDL-TAGmetabolism and thus fasting TAG concentration
[39]. These finding are in consistency with recent data [40]
suggesting that disturbance in energy balance leading up to
more than 1 kg of visceral fat increase would be required
to achieve changes in plasma TAG concentration found in
our study. It is obvious that this increase in visceral or even
total body fat did not take place in the current study. Indeed,
our data demonstrate that body weight changes if any were
exclusively related to the changes in TBW. Thus, an increase
in plasma TAG concentration seen in both groups was most
likely related to significant and quite extensive changes in
macronutrient intake rather than changes in energy balance.
We found that insulin sensitivity as determined by
HOMAIR was not affected by supplementation.The expected
adverse effects of high CHO intake on insulin sensitivity
[41] could have been offset by the consumption of Cr and
Ala, which have previously been found to improve insulin
sensitivity. Ala supplementation has been shown to enhance
activation of adenosine monophosphate activated kinase
(AMPK), which subsequently enhanced insulin stimulated
Glu disposal and reduced fasting insulin [42]. Similarly, Cr
supplementation has been shown to improve Glu tolerance
[43] in healthy males undergoing aerobic training [43]. It
should be noted that due to very high cardiorespiratory
fitness, participants of this study had very low HOMAIR [44]
and thus may have preserved insulin sensitivity regardless of
highCHO intake. In addition there is evidence to suggest that
increasing CHO intake improves rather than impairs glucose
tolerance [45]. Thus, the adverse effects of acute increase in
CHO intake on plasma lipid concentration can be expected to
be balanced either by no effect or potentially by a favourable
influence on Glu tolerance. We appreciate that not using
the gold standard technique, euglycemic hyperinsulinemic
clamp, for the assessment of insulin sensitivity and consider-
ing only fasting concentrations of insulin and Glumight have
limited revealing impact on insulin and Glu dynamic.
5. Conclusion
In conclusion, in endurance-trained individuals, short-term
increase in available CHO intake, through the Cr/Gly/Glu
hyperhydrating supplement which has been used prior to
exercise in the heat, causes a significant increase in plasma
TAG concentration and the TAG to HDL-cholesterol ratio.
These detrimental changes cannot be attenuated by partial
replacement of Glu with insulin-potentiating agent such as
Ala.These findings should be of potential interest not only to
scientists but also to athletes, coaches, and sports dietitians.
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